Company profile: Acurian
1.1 - Company Overview
Company description
- Provider of patient and doctor recruitment, enrollment and retention solutions for clinical trials, including recruitment feasibility, site identification and selection, data-driven patient recruitment, an integrated network for AES research sites, geo-targeted vaccine volunteer enrollment via a global site network, specialized strategies for challenging indications (Alzheimer's, NASH), and cancer solutions.
Products and services
- Integrated Network & Patient Recruitment: A centralized system that recruits patients into AES research sites, offering consistent operations and quality data across the network for dependable enrollment performance
- Patient Recruitment: A data-driven system that identifies and engages patients for clinical trials, ensuring timely and budget-friendly enrollment through streamlined patient identification and engagement
- Recruiting for Challenging Indications: A specialized system for difficult-to-enroll conditions like Alzheimer's and NASH that utilizes targeted databases and screening capabilities to recruit patients
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Acurian
Molecular Medicine
HQ: United States
Website
- Description: Provider of process R&D, process and assay development, clinical manufacturing, fill/finish, and GMP storage services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Molecular Medicine company profile →
Rhenovia
HQ: France
Website
- Description: Provider of applications of biosimulation rooted in neuroscience and nervous system modeling, from a French biotechnology company founded in 2007 by managers from large pharmaceutical companies and world experts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Rhenovia company profile →
Dalton Pharma Services
HQ: Canada
Website
- Description: Provider of cGMP contract drug discovery, development, and manufacturing services to pharmaceutical and biotechnology industries. FDA-registered and Health Canada approved with over 30 years of experience. Offerings include cGMP API manufacturing, custom chemical synthesis, formulation development, sterile filling services, accelerated stability testing, and conjugation services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dalton Pharma Services company profile →
Leukocare
HQ: Germany
Website
- Description: Provider of biopharmaceutical formulation development services operating at the interface of drug substance and drug product, combining bioinformatics, artificial intelligence and data science. Offerings include drug substance characterization, developability assessment, particle characterization, stability studies, and in silico analytics to optimize and accelerate development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Leukocare company profile →
Prothya Biosolutions
HQ: Belgium
Website
- Description: Provider of plasma protein therapeutics and services, including immunoglobulin for primary/secondary immunodeficiency and neuromuscular disorders (MMN, CIDP); albumin for blood loss, burns, and sepsis; prothrombin complex and Cofact for coagulation disorders. Offers product/process development (viral safety, formulations, stability, characterization) and contract manufacturing of plasma intermediates, APIs, drug substances, and final products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prothya Biosolutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Acurian
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Acurian
2.2 - Growth funds investing in similar companies to Acurian
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Acurian
4.2 - Public trading comparable groups for Acurian
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →